The University of Chicago Header Logo

Connection

Adena Hartstein to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Adena Hartstein has written about Drug Evaluation, Preclinical.
Adena Hartstein
Connection Strength
0.040
Drug Evaluation, Preclinical
  1. Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic. Mol Endocrinol. 2009 Mar; 23(3):412-21.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.